Sanket Koul

Forced reroutes from Hormuz for ships carrying construction material may raise input costs, delay timelines and push up ultra-luxury housing prices in key cities

Homeland Group and VRC acquire two prime land parcels in Mohali via GMADA auction, planning large mixed-use projects with premium residential and commercial spaces

Firms may shift to doctor outreach, CME programmes and patient support initiatives as CDSCO bars advertising of GLP-1 drugs ahead of semaglutide patent expiry

Union Health Ministry directs research bodies to refrain from informal data sharing and collaborations with foreign agencies without prior approval from competent authorities

Realty company to invest ₹1,000 crore in project featuring 57 floors; construction to be completed by 2031

CDSCO's DTAB panel proposes boxed warnings on emergency contraceptive pills and inclusion under Schedule K to ensure safer usage while retaining over-the-counter availability

The matter has been posted for hearing on May 21

UAE citizens, NRIs, family offices, regional investment groups evaluating India to broaden their allocation strategies

Experts say 2026 could be a crucial year for drug patents, with the likely emergence of fresh disputes over follow-on patents

CDSCO has mandated online submission of applications for licences to manufacture and sell r-DNA-origin drugs through the ONDLS portal to streamline regulatory processes

India's REIT market has grown more than six-fold since FY20 to Rs 1,726 billion in the first nine months of FY26, supported by new listings and steady unit price appreciation, CBRE said

Indian hospital chains report up to 30% drop in overseas patient inflow and revenue hit as the West Asia conflict disrupts medical travel and slows arrivals from key markets

Wholly owned subsidiary Ecoworld's Rs 1,125 cr fund raise also approved

Company plans to use proceeds from the Navi Mumbai asset sale to prepay debt and strengthen investments in artificial intelligence-led proptech platforms

India's indoor amusement industry has reached ₹15,000 crore as consumer spending rises, though high GST and regulatory gaps could affect expansion, says Anarock-IAAPI report

Drug regulator warns pharma companies that obesity awareness drives linked to GLP-1 drugs could amount to misleading promotion of prescription medicines

Union Health Ministry moves to remove repeated HIV, Hepatitis tests on pooled plasma to align with global norms and ease compliance while maintaining patient safety

The Centre will conduct a nationwide assessment of district hospitals to identify gaps in emergency and trauma care infrastructure and strengthen facilities in line with IPHS norms

Addressing the concluding session of the webinar, Dr VK Paul, member (health) at government think tank NITI Aayog said that the strategic way forward includes strengthening existing institutions

Bhagwati Products has leased 430,000 sq ft in Oppo's Noida plant to expand smartphone output, marking another major industrial space deal amid strong demand in NCR's manufacturing hubs